secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2025-12-18T23:59:59+00:00
Accession:  0001140361-25-045950
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys receives FDA 510(k) clearance for next-gen FemVue Controlled device
---------------------------------------------------------------------------

- FDA 510(k) clearance for FemVue Controlled, integrating FemVue and FemChec technologies.
- Single-device solution for controlled contrast delivery to evaluate fallopian tube status.
- Designed to enable multiple clinical uses and streamline manufacturing and practice workflows.
- CEO Kathy Lee-Sepsick highlights milestone as advancing clinician-focused innovations.
- NASDAQ-ticker FEMY; clearance announced December 18, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036125045950/0001140361-25-045950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036125045950/ef20061522_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-045950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer